nodes	percent_of_prediction	percent_of_DWPC	metapath
Oxprenolol—ADRB1—stomach cancer	0.514	0.543	CbGaD
Oxprenolol—ADRB2—stomach cancer	0.432	0.457	CbGaD
Oxprenolol—Emotional distress—Fluorouracil—stomach cancer	0.0021	0.0533	CcSEcCtD
Oxprenolol—Methocarbamol—CA1—stomach cancer	0.00165	0.147	CrCbGaD
Oxprenolol—Thrombocytopenia—Floxuridine—stomach cancer	0.000957	0.0242	CcSEcCtD
Oxprenolol—Abdominal pain—Floxuridine—stomach cancer	0.000773	0.0196	CcSEcCtD
Oxprenolol—Thrombocytopenia—Mitomycin—stomach cancer	0.000751	0.019	CcSEcCtD
Oxprenolol—Hypersensitivity—Floxuridine—stomach cancer	0.00072	0.0182	CcSEcCtD
Oxprenolol—Asthenia—Floxuridine—stomach cancer	0.000702	0.0178	CcSEcCtD
Oxprenolol—Diarrhoea—Floxuridine—stomach cancer	0.000669	0.0169	CcSEcCtD
Oxprenolol—Cardiac failure—Fluorouracil—stomach cancer	0.000665	0.0168	CcSEcCtD
Oxprenolol—Fatigue—Mitomycin—stomach cancer	0.000662	0.0167	CcSEcCtD
Oxprenolol—Practolol—ADRB1—stomach cancer	0.000661	0.059	CrCbGaD
Oxprenolol—Orthostatic hypotension—Irinotecan—stomach cancer	0.000619	0.0157	CcSEcCtD
Oxprenolol—Headache—Floxuridine—stomach cancer	0.000613	0.0155	CcSEcCtD
Oxprenolol—Metipranolol—ADRB1—stomach cancer	0.000598	0.0533	CrCbGaD
Oxprenolol—Nausea—Floxuridine—stomach cancer	0.000581	0.0147	CcSEcCtD
Oxprenolol—Sweating increased—Irinotecan—stomach cancer	0.000571	0.0144	CcSEcCtD
Oxprenolol—Asthenia—Mitomycin—stomach cancer	0.00055	0.0139	CcSEcCtD
Oxprenolol—Diarrhoea—Mitomycin—stomach cancer	0.000525	0.0133	CcSEcCtD
Oxprenolol—Dizziness—Mitomycin—stomach cancer	0.000507	0.0128	CcSEcCtD
Oxprenolol—Metipranolol—ADRB2—stomach cancer	0.000503	0.0448	CrCbGaD
Oxprenolol—Headache—Mitomycin—stomach cancer	0.000481	0.0122	CcSEcCtD
Oxprenolol—Cardiac failure—Docetaxel—stomach cancer	0.00048	0.0122	CcSEcCtD
Oxprenolol—Bradycardia—Irinotecan—stomach cancer	0.000477	0.0121	CcSEcCtD
Oxprenolol—Esmolol—ADRB1—stomach cancer	0.000475	0.0424	CrCbGaD
Oxprenolol—Cardiac failure—Capecitabine—stomach cancer	0.000465	0.0118	CcSEcCtD
Oxprenolol—Nausea—Mitomycin—stomach cancer	0.000456	0.0115	CcSEcCtD
Oxprenolol—Diplopia—Capecitabine—stomach cancer	0.000454	0.0115	CcSEcCtD
Oxprenolol—Abnormal dreams—Epirubicin—stomach cancer	0.00043	0.0109	CcSEcCtD
Oxprenolol—Orthostatic hypotension—Docetaxel—stomach cancer	0.000428	0.0108	CcSEcCtD
Oxprenolol—Betaxolol—ADRB1—stomach cancer	0.000418	0.0373	CrCbGaD
Oxprenolol—Orthostatic hypotension—Capecitabine—stomach cancer	0.000414	0.0105	CcSEcCtD
Oxprenolol—Atenolol—ADRB1—stomach cancer	0.000414	0.037	CrCbGaD
Oxprenolol—Penbutolol—ADRB1—stomach cancer	0.000414	0.037	CrCbGaD
Oxprenolol—Bisoprolol—ADRB1—stomach cancer	0.000404	0.036	CrCbGaD
Oxprenolol—Esmolol—ADRB2—stomach cancer	0.000399	0.0356	CrCbGaD
Oxprenolol—Bronchospasm—Docetaxel—stomach cancer	0.000398	0.0101	CcSEcCtD
Oxprenolol—Abnormal dreams—Doxorubicin—stomach cancer	0.000398	0.0101	CcSEcCtD
Oxprenolol—Bronchospasm—Capecitabine—stomach cancer	0.000386	0.00976	CcSEcCtD
Oxprenolol—Acebutolol—ADRB1—stomach cancer	0.000382	0.0341	CrCbGaD
Oxprenolol—Sweating increased—Capecitabine—stomach cancer	0.000382	0.00967	CcSEcCtD
Oxprenolol—Penbutolol—HTR1A—stomach cancer	0.000371	0.0331	CrCbGaD
Oxprenolol—Betaxolol—ADRB2—stomach cancer	0.000352	0.0314	CrCbGaD
Oxprenolol—Penbutolol—ADRB2—stomach cancer	0.000348	0.0311	CrCbGaD
Oxprenolol—Atenolol—ADRB2—stomach cancer	0.000348	0.0311	CrCbGaD
Oxprenolol—Alprenolol—ADRB1—stomach cancer	0.000347	0.031	CrCbGaD
Oxprenolol—Bisoprolol—ADRB2—stomach cancer	0.00034	0.0303	CrCbGaD
Oxprenolol—Thrombocytopenia—Irinotecan—stomach cancer	0.000326	0.00826	CcSEcCtD
Oxprenolol—Hypoglycaemia—Epirubicin—stomach cancer	0.000324	0.0082	CcSEcCtD
Oxprenolol—Cardiac failure—Epirubicin—stomach cancer	0.000324	0.0082	CcSEcCtD
Oxprenolol—Metoprolol—ADRB1—stomach cancer	0.000323	0.0288	CrCbGaD
Oxprenolol—Hyperhidrosis—Irinotecan—stomach cancer	0.000322	0.00815	CcSEcCtD
Oxprenolol—Acebutolol—ADRB2—stomach cancer	0.000322	0.0287	CrCbGaD
Oxprenolol—Bradycardia—Capecitabine—stomach cancer	0.00032	0.00809	CcSEcCtD
Oxprenolol—Diplopia—Epirubicin—stomach cancer	0.000316	0.008	CcSEcCtD
Oxprenolol—Thrombocytopenia—Fluorouracil—stomach cancer	0.000312	0.00791	CcSEcCtD
Oxprenolol—Hypotension—Irinotecan—stomach cancer	0.000311	0.00788	CcSEcCtD
Oxprenolol—Alprenolol—HTR1A—stomach cancer	0.000311	0.0277	CrCbGaD
Oxprenolol—Insomnia—Irinotecan—stomach cancer	0.000301	0.00763	CcSEcCtD
Oxprenolol—Hypoglycaemia—Doxorubicin—stomach cancer	0.0003	0.00759	CcSEcCtD
Oxprenolol—Cardiac failure—Doxorubicin—stomach cancer	0.0003	0.00759	CcSEcCtD
Oxprenolol—Pindolol—ADRB1—stomach cancer	0.000299	0.0266	CrCbGaD
Oxprenolol—Hypotension—Fluorouracil—stomach cancer	0.000298	0.00755	CcSEcCtD
Oxprenolol—Dyspepsia—Irinotecan—stomach cancer	0.000293	0.00742	CcSEcCtD
Oxprenolol—Diplopia—Doxorubicin—stomach cancer	0.000292	0.0074	CcSEcCtD
Oxprenolol—Alprenolol—ADRB2—stomach cancer	0.000292	0.026	CrCbGaD
Oxprenolol—Musculoskeletal discomfort—Fluorouracil—stomach cancer	0.000291	0.00736	CcSEcCtD
Oxprenolol—Orthostatic hypotension—Epirubicin—stomach cancer	0.000289	0.00731	CcSEcCtD
Oxprenolol—Insomnia—Fluorouracil—stomach cancer	0.000289	0.00731	CcSEcCtD
Oxprenolol—Fatigue—Irinotecan—stomach cancer	0.000287	0.00727	CcSEcCtD
Oxprenolol—Dyspepsia—Fluorouracil—stomach cancer	0.000281	0.00711	CcSEcCtD
Oxprenolol—Metoprolol—ADRB2—stomach cancer	0.000271	0.0242	CrCbGaD
Oxprenolol—Pindolol—HTR1A—stomach cancer	0.000267	0.0238	CrCbGaD
Oxprenolol—Orthostatic hypotension—Doxorubicin—stomach cancer	0.000267	0.00676	CcSEcCtD
Oxprenolol—Abdominal pain—Irinotecan—stomach cancer	0.000263	0.00667	CcSEcCtD
Oxprenolol—Pindolol—ADRB2—stomach cancer	0.000251	0.0224	CrCbGaD
Oxprenolol—Palpitations—Docetaxel—stomach cancer	0.000249	0.00631	CcSEcCtD
Oxprenolol—Hypersensitivity—Irinotecan—stomach cancer	0.000246	0.00621	CcSEcCtD
Oxprenolol—Palpitations—Capecitabine—stomach cancer	0.000241	0.00611	CcSEcCtD
Oxprenolol—Arthralgia—Docetaxel—stomach cancer	0.00024	0.00608	CcSEcCtD
Oxprenolol—Asthenia—Irinotecan—stomach cancer	0.000239	0.00605	CcSEcCtD
Oxprenolol—Hypersensitivity—Fluorouracil—stomach cancer	0.000235	0.00595	CcSEcCtD
Oxprenolol—Arthralgia—Capecitabine—stomach cancer	0.000233	0.00589	CcSEcCtD
Oxprenolol—Diarrhoea—Irinotecan—stomach cancer	0.000228	0.00577	CcSEcCtD
Oxprenolol—Pruritus—Fluorouracil—stomach cancer	0.000226	0.00572	CcSEcCtD
Oxprenolol—Thrombocytopenia—Docetaxel—stomach cancer	0.000226	0.00571	CcSEcCtD
Oxprenolol—Bradycardia—Epirubicin—stomach cancer	0.000223	0.00564	CcSEcCtD
Oxprenolol—Dizziness—Irinotecan—stomach cancer	0.00022	0.00558	CcSEcCtD
Oxprenolol—Diarrhoea—Fluorouracil—stomach cancer	0.000218	0.00553	CcSEcCtD
Oxprenolol—Thrombocytopenia—Capecitabine—stomach cancer	0.000218	0.00553	CcSEcCtD
Oxprenolol—Hyperhidrosis—Capecitabine—stomach cancer	0.000216	0.00546	CcSEcCtD
Oxprenolol—Hypotension—Docetaxel—stomach cancer	0.000215	0.00545	CcSEcCtD
Oxprenolol—Dizziness—Fluorouracil—stomach cancer	0.000211	0.00534	CcSEcCtD
Oxprenolol—Musculoskeletal discomfort—Docetaxel—stomach cancer	0.00021	0.00531	CcSEcCtD
Oxprenolol—Headache—Irinotecan—stomach cancer	0.000209	0.00528	CcSEcCtD
Oxprenolol—Hypotension—Capecitabine—stomach cancer	0.000208	0.00527	CcSEcCtD
Oxprenolol—Insomnia—Docetaxel—stomach cancer	0.000208	0.00527	CcSEcCtD
Oxprenolol—Bradycardia—Doxorubicin—stomach cancer	0.000206	0.00521	CcSEcCtD
Oxprenolol—Musculoskeletal discomfort—Capecitabine—stomach cancer	0.000203	0.00514	CcSEcCtD
Oxprenolol—Dyspepsia—Docetaxel—stomach cancer	0.000203	0.00513	CcSEcCtD
Oxprenolol—Insomnia—Capecitabine—stomach cancer	0.000202	0.00511	CcSEcCtD
Oxprenolol—Headache—Fluorouracil—stomach cancer	0.0002	0.00506	CcSEcCtD
Oxprenolol—Fatigue—Docetaxel—stomach cancer	0.000199	0.00503	CcSEcCtD
Oxprenolol—Nausea—Irinotecan—stomach cancer	0.000198	0.00501	CcSEcCtD
Oxprenolol—Dyspepsia—Capecitabine—stomach cancer	0.000196	0.00497	CcSEcCtD
Oxprenolol—Fatigue—Capecitabine—stomach cancer	0.000192	0.00487	CcSEcCtD
Oxprenolol—Nausea—Fluorouracil—stomach cancer	0.00019	0.0048	CcSEcCtD
Oxprenolol—Abdominal pain—Docetaxel—stomach cancer	0.000182	0.00461	CcSEcCtD
Oxprenolol—Abdominal pain—Capecitabine—stomach cancer	0.000176	0.00446	CcSEcCtD
Oxprenolol—Arthralgia—Methotrexate—stomach cancer	0.000173	0.00438	CcSEcCtD
Oxprenolol—Hypersensitivity—Docetaxel—stomach cancer	0.00017	0.0043	CcSEcCtD
Oxprenolol—Palpitations—Epirubicin—stomach cancer	0.000168	0.00426	CcSEcCtD
Oxprenolol—Asthenia—Docetaxel—stomach cancer	0.000165	0.00418	CcSEcCtD
Oxprenolol—Hypersensitivity—Capecitabine—stomach cancer	0.000164	0.00416	CcSEcCtD
Oxprenolol—Pruritus—Docetaxel—stomach cancer	0.000163	0.00412	CcSEcCtD
Oxprenolol—Propranolol—ADRB1—stomach cancer	0.000163	0.0145	CrCbGaD
Oxprenolol—Thrombocytopenia—Methotrexate—stomach cancer	0.000163	0.00411	CcSEcCtD
Oxprenolol—Arthralgia—Epirubicin—stomach cancer	0.000162	0.0041	CcSEcCtD
Oxprenolol—Hyperhidrosis—Methotrexate—stomach cancer	0.00016	0.00406	CcSEcCtD
Oxprenolol—Asthenia—Capecitabine—stomach cancer	0.00016	0.00405	CcSEcCtD
Oxprenolol—Pruritus—Capecitabine—stomach cancer	0.000158	0.00399	CcSEcCtD
Oxprenolol—Diarrhoea—Docetaxel—stomach cancer	0.000158	0.00399	CcSEcCtD
Oxprenolol—Palpitations—Doxorubicin—stomach cancer	0.000156	0.00394	CcSEcCtD
Oxprenolol—Hypotension—Methotrexate—stomach cancer	0.000155	0.00393	CcSEcCtD
Oxprenolol—Diarrhoea—Capecitabine—stomach cancer	0.000153	0.00386	CcSEcCtD
Oxprenolol—Dizziness—Docetaxel—stomach cancer	0.000152	0.00386	CcSEcCtD
Oxprenolol—Thrombocytopenia—Epirubicin—stomach cancer	0.000152	0.00385	CcSEcCtD
Oxprenolol—Musculoskeletal discomfort—Methotrexate—stomach cancer	0.000151	0.00383	CcSEcCtD
Oxprenolol—Hyperhidrosis—Epirubicin—stomach cancer	0.00015	0.0038	CcSEcCtD
Oxprenolol—Insomnia—Methotrexate—stomach cancer	0.00015	0.0038	CcSEcCtD
Oxprenolol—Arthralgia—Doxorubicin—stomach cancer	0.00015	0.0038	CcSEcCtD
Oxprenolol—Dizziness—Capecitabine—stomach cancer	0.000147	0.00373	CcSEcCtD
Oxprenolol—Dyspepsia—Methotrexate—stomach cancer	0.000146	0.0037	CcSEcCtD
Oxprenolol—Propranolol—HTR1A—stomach cancer	0.000146	0.013	CrCbGaD
Oxprenolol—Hypotension—Epirubicin—stomach cancer	0.000145	0.00367	CcSEcCtD
Oxprenolol—Headache—Docetaxel—stomach cancer	0.000144	0.00365	CcSEcCtD
Oxprenolol—Fatigue—Methotrexate—stomach cancer	0.000143	0.00362	CcSEcCtD
Oxprenolol—Musculoskeletal discomfort—Epirubicin—stomach cancer	0.000142	0.00358	CcSEcCtD
Oxprenolol—Thrombocytopenia—Doxorubicin—stomach cancer	0.000141	0.00356	CcSEcCtD
Oxprenolol—Insomnia—Epirubicin—stomach cancer	0.000141	0.00356	CcSEcCtD
Oxprenolol—Headache—Capecitabine—stomach cancer	0.00014	0.00354	CcSEcCtD
Oxprenolol—Hyperhidrosis—Doxorubicin—stomach cancer	0.000139	0.00352	CcSEcCtD
Oxprenolol—Propranolol—ADRB2—stomach cancer	0.000137	0.0122	CrCbGaD
Oxprenolol—Nausea—Docetaxel—stomach cancer	0.000137	0.00346	CcSEcCtD
Oxprenolol—Dyspepsia—Epirubicin—stomach cancer	0.000137	0.00346	CcSEcCtD
Oxprenolol—Hypotension—Doxorubicin—stomach cancer	0.000134	0.0034	CcSEcCtD
Oxprenolol—Fatigue—Epirubicin—stomach cancer	0.000134	0.00339	CcSEcCtD
Oxprenolol—Nausea—Capecitabine—stomach cancer	0.000132	0.00335	CcSEcCtD
Oxprenolol—Abdominal pain—Methotrexate—stomach cancer	0.000131	0.00332	CcSEcCtD
Oxprenolol—Musculoskeletal discomfort—Doxorubicin—stomach cancer	0.000131	0.00332	CcSEcCtD
Oxprenolol—Insomnia—Doxorubicin—stomach cancer	0.00013	0.00329	CcSEcCtD
Oxprenolol—Dyspepsia—Doxorubicin—stomach cancer	0.000127	0.0032	CcSEcCtD
Oxprenolol—Fatigue—Doxorubicin—stomach cancer	0.000124	0.00314	CcSEcCtD
Oxprenolol—Abdominal pain—Epirubicin—stomach cancer	0.000123	0.00311	CcSEcCtD
Oxprenolol—Hypersensitivity—Methotrexate—stomach cancer	0.000122	0.0031	CcSEcCtD
Oxprenolol—Asthenia—Methotrexate—stomach cancer	0.000119	0.00301	CcSEcCtD
Oxprenolol—Pruritus—Methotrexate—stomach cancer	0.000117	0.00297	CcSEcCtD
Oxprenolol—Hypersensitivity—Epirubicin—stomach cancer	0.000114	0.0029	CcSEcCtD
Oxprenolol—Abdominal pain—Doxorubicin—stomach cancer	0.000114	0.00288	CcSEcCtD
Oxprenolol—Diarrhoea—Methotrexate—stomach cancer	0.000114	0.00288	CcSEcCtD
Oxprenolol—Asthenia—Epirubicin—stomach cancer	0.000111	0.00282	CcSEcCtD
Oxprenolol—Pruritus—Epirubicin—stomach cancer	0.00011	0.00278	CcSEcCtD
Oxprenolol—Dizziness—Methotrexate—stomach cancer	0.00011	0.00278	CcSEcCtD
Oxprenolol—Diarrhoea—Epirubicin—stomach cancer	0.000106	0.00269	CcSEcCtD
Oxprenolol—Hypersensitivity—Doxorubicin—stomach cancer	0.000106	0.00268	CcSEcCtD
Oxprenolol—Headache—Methotrexate—stomach cancer	0.000104	0.00263	CcSEcCtD
Oxprenolol—Asthenia—Doxorubicin—stomach cancer	0.000103	0.00261	CcSEcCtD
Oxprenolol—Dizziness—Epirubicin—stomach cancer	0.000103	0.0026	CcSEcCtD
Oxprenolol—Pruritus—Doxorubicin—stomach cancer	0.000102	0.00257	CcSEcCtD
Oxprenolol—Nausea—Methotrexate—stomach cancer	9.86e-05	0.0025	CcSEcCtD
Oxprenolol—Diarrhoea—Doxorubicin—stomach cancer	9.84e-05	0.00249	CcSEcCtD
Oxprenolol—Headache—Epirubicin—stomach cancer	9.73e-05	0.00246	CcSEcCtD
Oxprenolol—Dizziness—Doxorubicin—stomach cancer	9.51e-05	0.00241	CcSEcCtD
Oxprenolol—Nausea—Epirubicin—stomach cancer	9.23e-05	0.00234	CcSEcCtD
Oxprenolol—Headache—Doxorubicin—stomach cancer	9.01e-05	0.00228	CcSEcCtD
Oxprenolol—Nausea—Doxorubicin—stomach cancer	8.54e-05	0.00216	CcSEcCtD
Oxprenolol—ADRB1—GPCR downstream signaling—F2R—stomach cancer	4.35e-06	0.00141	CbGpPWpGaD
Oxprenolol—CYP2D6—Metabolism—GMPR2—stomach cancer	4.34e-06	0.00141	CbGpPWpGaD
Oxprenolol—ADRB2—GPCR downstream signaling—AGTR2—stomach cancer	4.3e-06	0.0014	CbGpPWpGaD
Oxprenolol—ADRB2—Signaling Pathways—WWOX—stomach cancer	4.27e-06	0.00139	CbGpPWpGaD
Oxprenolol—ADRB2—GPCR downstream signaling—F2R—stomach cancer	4.25e-06	0.00138	CbGpPWpGaD
Oxprenolol—ADRB1—GPCR downstream signaling—HTR1A—stomach cancer	4.23e-06	0.00137	CbGpPWpGaD
Oxprenolol—ADRB2—GPCR downstream signaling—HTR1A—stomach cancer	4.14e-06	0.00134	CbGpPWpGaD
Oxprenolol—SLC22A2—Metabolism—PDHA1—stomach cancer	4.12e-06	0.00134	CbGpPWpGaD
Oxprenolol—SLC22A2—Metabolism—ECHS1—stomach cancer	4.12e-06	0.00134	CbGpPWpGaD
Oxprenolol—ADRB1—GPCR downstream signaling—ANXA1—stomach cancer	4.09e-06	0.00133	CbGpPWpGaD
Oxprenolol—ADRB1—Signaling Pathways—WIF1—stomach cancer	4.06e-06	0.00132	CbGpPWpGaD
Oxprenolol—ADRB1—Signaling Pathways—HRH4—stomach cancer	4.06e-06	0.00132	CbGpPWpGaD
Oxprenolol—ADRB2—GPCR downstream signaling—ANXA1—stomach cancer	4e-06	0.0013	CbGpPWpGaD
Oxprenolol—ADRB1—Signaling by GPCR—AGTR2—stomach cancer	3.99e-06	0.0013	CbGpPWpGaD
Oxprenolol—ADRB2—Signaling Pathways—WIF1—stomach cancer	3.97e-06	0.00129	CbGpPWpGaD
Oxprenolol—ADRB2—Signaling Pathways—HRH4—stomach cancer	3.97e-06	0.00129	CbGpPWpGaD
Oxprenolol—CYP2D6—Metabolism—SUCLG1—stomach cancer	3.97e-06	0.00129	CbGpPWpGaD
Oxprenolol—CYP2D6—Metabolism—IDH3B—stomach cancer	3.97e-06	0.00129	CbGpPWpGaD
Oxprenolol—SLC22A2—Transmembrane transport of small molecules—HMOX1—stomach cancer	3.96e-06	0.00129	CbGpPWpGaD
Oxprenolol—ADRB1—Signaling by GPCR—F2R—stomach cancer	3.95e-06	0.00128	CbGpPWpGaD
Oxprenolol—ADRB2—Signaling by GPCR—AGTR2—stomach cancer	3.9e-06	0.00127	CbGpPWpGaD
Oxprenolol—ADRB2—GPCR downstream signaling—ADRB1—stomach cancer	3.87e-06	0.00126	CbGpPWpGaD
Oxprenolol—SLC22A2—Metabolism—TYMP—stomach cancer	3.87e-06	0.00126	CbGpPWpGaD
Oxprenolol—SLC22A2—Metabolism—FADS1—stomach cancer	3.87e-06	0.00126	CbGpPWpGaD
Oxprenolol—ADRB2—Signaling by GPCR—F2R—stomach cancer	3.86e-06	0.00125	CbGpPWpGaD
Oxprenolol—ADRB1—Signaling by GPCR—HTR1A—stomach cancer	3.84e-06	0.00125	CbGpPWpGaD
Oxprenolol—ADRB2—Signaling by GPCR—HTR1A—stomach cancer	3.76e-06	0.00122	CbGpPWpGaD
Oxprenolol—ADRB1—Signaling Pathways—PRKAB1—stomach cancer	3.75e-06	0.00122	CbGpPWpGaD
Oxprenolol—ADRB1—Signaling by GPCR—ANXA1—stomach cancer	3.71e-06	0.0012	CbGpPWpGaD
Oxprenolol—CYP2D6—Metabolism—NDUFV1—stomach cancer	3.69e-06	0.0012	CbGpPWpGaD
Oxprenolol—CYP2D6—Metabolism—NDUFS1—stomach cancer	3.69e-06	0.0012	CbGpPWpGaD
Oxprenolol—ADRB2—Signaling Pathways—PRKAB1—stomach cancer	3.66e-06	0.00119	CbGpPWpGaD
Oxprenolol—ADRB2—Signaling by GPCR—ANXA1—stomach cancer	3.63e-06	0.00118	CbGpPWpGaD
Oxprenolol—SLC22A2—Metabolism—SREBF2—stomach cancer	3.63e-06	0.00118	CbGpPWpGaD
Oxprenolol—ADRB1—Signaling Pathways—KISS1—stomach cancer	3.62e-06	0.00117	CbGpPWpGaD
Oxprenolol—ADRB1—Signaling Pathways—RNF43—stomach cancer	3.62e-06	0.00117	CbGpPWpGaD
Oxprenolol—ADRB1—Class A/1 (Rhodopsin-like receptors)—CXCL8—stomach cancer	3.6e-06	0.00117	CbGpPWpGaD
Oxprenolol—SLC22A2—Transmission across Chemical Synapses—MAPK1—stomach cancer	3.58e-06	0.00116	CbGpPWpGaD
Oxprenolol—SLC22A2—Metabolism—RORA—stomach cancer	3.58e-06	0.00116	CbGpPWpGaD
Oxprenolol—ADRB2—Signaling Pathways—RNF43—stomach cancer	3.54e-06	0.00115	CbGpPWpGaD
Oxprenolol—ADRB2—Signaling Pathways—KISS1—stomach cancer	3.54e-06	0.00115	CbGpPWpGaD
Oxprenolol—ADRB2—Class A/1 (Rhodopsin-like receptors)—CXCL8—stomach cancer	3.52e-06	0.00114	CbGpPWpGaD
Oxprenolol—ADRB2—Signaling by GPCR—ADRB1—stomach cancer	3.52e-06	0.00114	CbGpPWpGaD
Oxprenolol—SLC22A2—Metabolism—ALDOB—stomach cancer	3.36e-06	0.00109	CbGpPWpGaD
Oxprenolol—CYP2D6—Metabolism—BLVRB—stomach cancer	3.29e-06	0.00107	CbGpPWpGaD
Oxprenolol—CYP2D6—Metabolism—PGLS—stomach cancer	3.29e-06	0.00107	CbGpPWpGaD
Oxprenolol—ADRB1—Signaling Pathways—FST—stomach cancer	3.23e-06	0.00105	CbGpPWpGaD
Oxprenolol—ADRB1—GPCR downstream signaling—ADRB2—stomach cancer	3.21e-06	0.00104	CbGpPWpGaD
Oxprenolol—ADRB1—Signaling by GPCR—HBEGF—stomach cancer	3.16e-06	0.00102	CbGpPWpGaD
Oxprenolol—ADRB2—Signaling Pathways—FST—stomach cancer	3.15e-06	0.00102	CbGpPWpGaD
Oxprenolol—CYP2D6—Metabolism—PPAP2A—stomach cancer	3.14e-06	0.00102	CbGpPWpGaD
Oxprenolol—SLC22A2—Metabolism—ALOX5—stomach cancer	3.12e-06	0.00101	CbGpPWpGaD
Oxprenolol—ADRB1—Signaling Pathways—RGS2—stomach cancer	3.11e-06	0.00101	CbGpPWpGaD
Oxprenolol—ADRB1—Signaling Pathways—GAST—stomach cancer	3.11e-06	0.00101	CbGpPWpGaD
Oxprenolol—ADRB2—Signaling by GPCR—HBEGF—stomach cancer	3.09e-06	0.001	CbGpPWpGaD
Oxprenolol—SLC22A2—Metabolism—DPYD—stomach cancer	3.07e-06	0.000996	CbGpPWpGaD
Oxprenolol—ADRB2—Signaling Pathways—RGS2—stomach cancer	3.04e-06	0.000988	CbGpPWpGaD
Oxprenolol—ADRB2—Signaling Pathways—GAST—stomach cancer	3.04e-06	0.000988	CbGpPWpGaD
Oxprenolol—SLC22A2—Transmembrane transport of small molecules—APOA1—stomach cancer	3e-06	0.000974	CbGpPWpGaD
Oxprenolol—ADRB1—Signaling Pathways—FGG—stomach cancer	2.95e-06	0.000957	CbGpPWpGaD
Oxprenolol—ADRB1—Signaling by GPCR—ADRB2—stomach cancer	2.91e-06	0.000945	CbGpPWpGaD
Oxprenolol—ADRB2—Signaling Pathways—FGG—stomach cancer	2.89e-06	0.000936	CbGpPWpGaD
Oxprenolol—SLC22A2—Transmission across Chemical Synapses—HRAS—stomach cancer	2.88e-06	0.000933	CbGpPWpGaD
Oxprenolol—ADRB1—Signaling by GPCR—PPP2R1A—stomach cancer	2.85e-06	0.000926	CbGpPWpGaD
Oxprenolol—ADRB1—Signaling Pathways—PRKAA1—stomach cancer	2.84e-06	0.000921	CbGpPWpGaD
Oxprenolol—CYP2D6—Metabolism—CKB—stomach cancer	2.8e-06	0.000908	CbGpPWpGaD
Oxprenolol—CYP2D6—Metabolism—CA1—stomach cancer	2.8e-06	0.000908	CbGpPWpGaD
Oxprenolol—CYP2D6—Metabolism—NDUFA2—stomach cancer	2.8e-06	0.000908	CbGpPWpGaD
Oxprenolol—CYP2D6—Metabolism—FBP1—stomach cancer	2.8e-06	0.000908	CbGpPWpGaD
Oxprenolol—ADRB2—Signaling by GPCR—PPP2R1A—stomach cancer	2.79e-06	0.000906	CbGpPWpGaD
Oxprenolol—ADRB2—Signaling Pathways—PRKAA1—stomach cancer	2.78e-06	0.000901	CbGpPWpGaD
Oxprenolol—SLC22A2—Neuronal System—MAPK1—stomach cancer	2.74e-06	0.000891	CbGpPWpGaD
Oxprenolol—ADRB1—Signaling Pathways—RBP4—stomach cancer	2.74e-06	0.00089	CbGpPWpGaD
Oxprenolol—ADRB1—GPCR ligand binding—CXCL8—stomach cancer	2.74e-06	0.000889	CbGpPWpGaD
Oxprenolol—SLC22A2—Metabolism—GSTT1—stomach cancer	2.71e-06	0.000881	CbGpPWpGaD
Oxprenolol—SLC22A2—Metabolism—CYP2A6—stomach cancer	2.68e-06	0.000871	CbGpPWpGaD
Oxprenolol—ADRB2—Signaling Pathways—RBP4—stomach cancer	2.68e-06	0.00087	CbGpPWpGaD
Oxprenolol—ADRB2—GPCR ligand binding—CXCL8—stomach cancer	2.68e-06	0.00087	CbGpPWpGaD
Oxprenolol—CYP2D6—Metabolism—PLIN2—stomach cancer	2.63e-06	0.000853	CbGpPWpGaD
Oxprenolol—SLC22A2—Metabolism—AKR1C3—stomach cancer	2.61e-06	0.000847	CbGpPWpGaD
Oxprenolol—CYP2D6—Metabolism—CA2—stomach cancer	2.56e-06	0.00083	CbGpPWpGaD
Oxprenolol—SLC22A2—Metabolism—ENO1—stomach cancer	2.54e-06	0.000826	CbGpPWpGaD
Oxprenolol—CYP2D6—Metabolism—NT5E—stomach cancer	2.49e-06	0.000809	CbGpPWpGaD
Oxprenolol—CYP2D6—Metabolism—PGAM1—stomach cancer	2.49e-06	0.000809	CbGpPWpGaD
Oxprenolol—SLC22A2—Transmembrane transport of small molecules—ALB—stomach cancer	2.38e-06	0.000772	CbGpPWpGaD
Oxprenolol—CYP2D6—Metabolism—ALDH7A1—stomach cancer	2.38e-06	0.000772	CbGpPWpGaD
Oxprenolol—CYP2D6—Metabolism—PLCE1—stomach cancer	2.38e-06	0.000772	CbGpPWpGaD
Oxprenolol—ADRB1—Signaling Pathways—HSPB1—stomach cancer	2.36e-06	0.000765	CbGpPWpGaD
Oxprenolol—ADRB1—Signaling Pathways—AGTR2—stomach cancer	2.36e-06	0.000765	CbGpPWpGaD
Oxprenolol—ADRB1—Signaling Pathways—BMP2—stomach cancer	2.33e-06	0.000757	CbGpPWpGaD
Oxprenolol—ADRB1—Signaling Pathways—F2R—stomach cancer	2.33e-06	0.000757	CbGpPWpGaD
Oxprenolol—ADRB2—Signaling Pathways—HSPB1—stomach cancer	2.31e-06	0.000749	CbGpPWpGaD
Oxprenolol—ADRB2—Signaling Pathways—AGTR2—stomach cancer	2.31e-06	0.000749	CbGpPWpGaD
Oxprenolol—ADRB1—Signaling Pathways—AKR1C3—stomach cancer	2.29e-06	0.000744	CbGpPWpGaD
Oxprenolol—ADRB2—Signaling Pathways—BMP2—stomach cancer	2.28e-06	0.00074	CbGpPWpGaD
Oxprenolol—ADRB2—Signaling Pathways—F2R—stomach cancer	2.28e-06	0.00074	CbGpPWpGaD
Oxprenolol—CYP2D6—Metabolism—UMPS—stomach cancer	2.28e-06	0.00074	CbGpPWpGaD
Oxprenolol—ADRB1—Signaling Pathways—HTR1A—stomach cancer	2.27e-06	0.000737	CbGpPWpGaD
Oxprenolol—SLC22A2—Metabolism—CD44—stomach cancer	2.26e-06	0.000732	CbGpPWpGaD
Oxprenolol—ADRB2—Signaling Pathways—AKR1C3—stomach cancer	2.24e-06	0.000728	CbGpPWpGaD
Oxprenolol—ADRB2—Signaling Pathways—HTR1A—stomach cancer	2.22e-06	0.000721	CbGpPWpGaD
Oxprenolol—SLC22A2—Neuronal System—HRAS—stomach cancer	2.2e-06	0.000715	CbGpPWpGaD
Oxprenolol—ADRB1—GPCR downstream signaling—PRKCB—stomach cancer	2.2e-06	0.000713	CbGpPWpGaD
Oxprenolol—ADRB1—Signaling Pathways—ANXA1—stomach cancer	2.19e-06	0.000711	CbGpPWpGaD
Oxprenolol—ADRB2—GPCR downstream signaling—PRKCB—stomach cancer	2.15e-06	0.000698	CbGpPWpGaD
Oxprenolol—ADRB2—Signaling Pathways—ANXA1—stomach cancer	2.14e-06	0.000696	CbGpPWpGaD
Oxprenolol—CYP2D6—Metabolism—ECHS1—stomach cancer	2.12e-06	0.000688	CbGpPWpGaD
Oxprenolol—CYP2D6—Metabolism—PDHA1—stomach cancer	2.12e-06	0.000688	CbGpPWpGaD
Oxprenolol—ADRB2—Signaling Pathways—ADRB1—stomach cancer	2.08e-06	0.000674	CbGpPWpGaD
Oxprenolol—ADRB1—Signaling Pathways—RPS6—stomach cancer	2.03e-06	0.000658	CbGpPWpGaD
Oxprenolol—ADRB1—Signaling by GPCR—PRKCB—stomach cancer	2e-06	0.000648	CbGpPWpGaD
Oxprenolol—CYP2D6—Metabolism—FADS1—stomach cancer	1.99e-06	0.000647	CbGpPWpGaD
Oxprenolol—CYP2D6—Metabolism—TYMP—stomach cancer	1.99e-06	0.000647	CbGpPWpGaD
Oxprenolol—ADRB1—Signaling by GPCR—IL6ST—stomach cancer	1.99e-06	0.000645	CbGpPWpGaD
Oxprenolol—ADRB2—Signaling Pathways—RPS6—stomach cancer	1.98e-06	0.000644	CbGpPWpGaD
Oxprenolol—ADRB2—Signaling by GPCR—PRKCB—stomach cancer	1.95e-06	0.000634	CbGpPWpGaD
Oxprenolol—ADRB2—Signaling by GPCR—IL6ST—stomach cancer	1.94e-06	0.000631	CbGpPWpGaD
Oxprenolol—SLC22A2—Metabolism—PPP2R1A—stomach cancer	1.92e-06	0.000623	CbGpPWpGaD
Oxprenolol—SLC22A2—Metabolism—GSTP1—stomach cancer	1.88e-06	0.000611	CbGpPWpGaD
Oxprenolol—CYP2D6—Metabolism—SREBF2—stomach cancer	1.87e-06	0.000606	CbGpPWpGaD
Oxprenolol—ADRB1—Signaling Pathways—HBEGF—stomach cancer	1.86e-06	0.000605	CbGpPWpGaD
Oxprenolol—SLC22A2—Metabolism—HMOX1—stomach cancer	1.86e-06	0.000602	CbGpPWpGaD
Oxprenolol—CYP2D6—Metabolism—RORA—stomach cancer	1.84e-06	0.000598	CbGpPWpGaD
Oxprenolol—ADRB2—Signaling Pathways—HBEGF—stomach cancer	1.82e-06	0.000592	CbGpPWpGaD
Oxprenolol—ADRB1—Signaling by GPCR—IL6R—stomach cancer	1.77e-06	0.000575	CbGpPWpGaD
Oxprenolol—ADRB1—GPCR downstream signaling—RHOA—stomach cancer	1.76e-06	0.000572	CbGpPWpGaD
Oxprenolol—SLC22A2—Metabolism—TYMS—stomach cancer	1.75e-06	0.000568	CbGpPWpGaD
Oxprenolol—ADRB2—Signaling by GPCR—IL6R—stomach cancer	1.73e-06	0.000563	CbGpPWpGaD
Oxprenolol—SLC22A2—Metabolism—GSTM1—stomach cancer	1.73e-06	0.000561	CbGpPWpGaD
Oxprenolol—CYP2D6—Metabolism—ALDOB—stomach cancer	1.73e-06	0.000561	CbGpPWpGaD
Oxprenolol—ADRB2—GPCR downstream signaling—RHOA—stomach cancer	1.73e-06	0.00056	CbGpPWpGaD
Oxprenolol—ADRB1—Signaling Pathways—ADRB2—stomach cancer	1.72e-06	0.000558	CbGpPWpGaD
Oxprenolol—ADRB1—Signaling Pathways—PPP2R1A—stomach cancer	1.69e-06	0.000547	CbGpPWpGaD
Oxprenolol—ADRB2—Signaling Pathways—PPP2R1A—stomach cancer	1.65e-06	0.000535	CbGpPWpGaD
Oxprenolol—SLC22A2—Metabolism—ERCC2—stomach cancer	1.63e-06	0.000528	CbGpPWpGaD
Oxprenolol—CYP2D6—Metabolism—ALOX5—stomach cancer	1.61e-06	0.000521	CbGpPWpGaD
Oxprenolol—ADRB1—Signaling by GPCR—RHOA—stomach cancer	1.6e-06	0.00052	CbGpPWpGaD
Oxprenolol—CYP2D6—Metabolism—DPYD—stomach cancer	1.58e-06	0.000513	CbGpPWpGaD
Oxprenolol—ADRB2—Signaling by GPCR—RHOA—stomach cancer	1.57e-06	0.000509	CbGpPWpGaD
Oxprenolol—ADRB1—Signaling Pathways—SMAD4—stomach cancer	1.57e-06	0.000508	CbGpPWpGaD
Oxprenolol—ADRB1—GPCR downstream signaling—CXCL8—stomach cancer	1.55e-06	0.000503	CbGpPWpGaD
Oxprenolol—ADRB2—Signaling Pathways—SMAD4—stomach cancer	1.53e-06	0.000497	CbGpPWpGaD
Oxprenolol—SLC22A2—Metabolism—MTHFR—stomach cancer	1.53e-06	0.000496	CbGpPWpGaD
Oxprenolol—ADRB2—GPCR downstream signaling—CXCL8—stomach cancer	1.52e-06	0.000492	CbGpPWpGaD
Oxprenolol—ADRB1—Signaling Pathways—FYN—stomach cancer	1.49e-06	0.000482	CbGpPWpGaD
Oxprenolol—ADRB2—Signaling Pathways—FYN—stomach cancer	1.45e-06	0.000472	CbGpPWpGaD
Oxprenolol—SLC22A2—Metabolism—CAV1—stomach cancer	1.41e-06	0.000457	CbGpPWpGaD
Oxprenolol—SLC22A2—Metabolism—APOA1—stomach cancer	1.41e-06	0.000456	CbGpPWpGaD
Oxprenolol—ADRB1—Signaling by GPCR—CXCL8—stomach cancer	1.41e-06	0.000456	CbGpPWpGaD
Oxprenolol—CYP2D6—Metabolism—GSTT1—stomach cancer	1.4e-06	0.000454	CbGpPWpGaD
Oxprenolol—ADRB1—Signaling Pathways—FGFR2—stomach cancer	1.4e-06	0.000453	CbGpPWpGaD
Oxprenolol—CYP2D6—Metabolism—CYP2A6—stomach cancer	1.38e-06	0.000448	CbGpPWpGaD
Oxprenolol—ADRB2—Signaling by GPCR—CXCL8—stomach cancer	1.38e-06	0.000446	CbGpPWpGaD
Oxprenolol—ADRB2—Signaling Pathways—FGFR2—stomach cancer	1.36e-06	0.000443	CbGpPWpGaD
Oxprenolol—CYP2D6—Metabolism—AKR1C3—stomach cancer	1.34e-06	0.000436	CbGpPWpGaD
Oxprenolol—CYP2D6—Metabolism—ENO1—stomach cancer	1.31e-06	0.000425	CbGpPWpGaD
Oxprenolol—ADRB1—Signaling Pathways—IRS2—stomach cancer	1.28e-06	0.000415	CbGpPWpGaD
Oxprenolol—ADRB2—Signaling Pathways—IRS2—stomach cancer	1.25e-06	0.000406	CbGpPWpGaD
Oxprenolol—SLC22A2—Metabolism—PPARG—stomach cancer	1.24e-06	0.000402	CbGpPWpGaD
Oxprenolol—ADRB1—Signaling Pathways—CAV1—stomach cancer	1.24e-06	0.000402	CbGpPWpGaD
Oxprenolol—ADRB1—Signaling Pathways—APOA1—stomach cancer	1.24e-06	0.000401	CbGpPWpGaD
Oxprenolol—ADRB2—Signaling Pathways—CAV1—stomach cancer	1.21e-06	0.000393	CbGpPWpGaD
Oxprenolol—ADRB2—Signaling Pathways—APOA1—stomach cancer	1.21e-06	0.000392	CbGpPWpGaD
Oxprenolol—ADRB1—Signaling Pathways—PRKCB—stomach cancer	1.18e-06	0.000383	CbGpPWpGaD
Oxprenolol—ADRB1—Signaling Pathways—IL6ST—stomach cancer	1.17e-06	0.000381	CbGpPWpGaD
Oxprenolol—CYP2D6—Metabolism—CD44—stomach cancer	1.16e-06	0.000377	CbGpPWpGaD
Oxprenolol—ADRB2—Signaling Pathways—PRKCB—stomach cancer	1.15e-06	0.000374	CbGpPWpGaD
Oxprenolol—ADRB2—Signaling Pathways—IL6ST—stomach cancer	1.15e-06	0.000373	CbGpPWpGaD
Oxprenolol—ADRB1—Signaling Pathways—APC—stomach cancer	1.13e-06	0.000366	CbGpPWpGaD
Oxprenolol—SLC22A2—Metabolism—ALB—stomach cancer	1.11e-06	0.000362	CbGpPWpGaD
Oxprenolol—ADRB2—Signaling Pathways—APC—stomach cancer	1.1e-06	0.000358	CbGpPWpGaD
Oxprenolol—ADRB1—Signaling by GPCR—MAPK3—stomach cancer	1.08e-06	0.000351	CbGpPWpGaD
Oxprenolol—SLC22A2—Metabolism—NOS3—stomach cancer	1.07e-06	0.000346	CbGpPWpGaD
Oxprenolol—ADRB2—Signaling by GPCR—MAPK3—stomach cancer	1.06e-06	0.000343	CbGpPWpGaD
Oxprenolol—ADRB1—Signaling Pathways—IL6R—stomach cancer	1.05e-06	0.00034	CbGpPWpGaD
Oxprenolol—ADRB1—Signaling by GPCR—MAPK1—stomach cancer	1.03e-06	0.000334	CbGpPWpGaD
Oxprenolol—ADRB1—Signaling by GPCR—EGFR—stomach cancer	1.03e-06	0.000334	CbGpPWpGaD
Oxprenolol—ADRB2—Signaling Pathways—IL6R—stomach cancer	1.02e-06	0.000333	CbGpPWpGaD
Oxprenolol—ADRB2—Signaling by GPCR—MAPK1—stomach cancer	1.01e-06	0.000326	CbGpPWpGaD
Oxprenolol—ADRB2—Signaling by GPCR—EGFR—stomach cancer	1.01e-06	0.000326	CbGpPWpGaD
Oxprenolol—CYP2D6—Metabolism—PPP2R1A—stomach cancer	9.88e-07	0.00032	CbGpPWpGaD
Oxprenolol—ADRB1—GPCR downstream signaling—PIK3CA—stomach cancer	9.82e-07	0.000319	CbGpPWpGaD
Oxprenolol—ADRB1—Signaling Pathways—SERPINE1—stomach cancer	9.81e-07	0.000318	CbGpPWpGaD
Oxprenolol—SLC22A2—Metabolism—PTGS2—stomach cancer	9.75e-07	0.000316	CbGpPWpGaD
Oxprenolol—ADRB1—Signaling by GPCR—KRAS—stomach cancer	9.71e-07	0.000315	CbGpPWpGaD
Oxprenolol—CYP2D6—Metabolism—GSTP1—stomach cancer	9.69e-07	0.000314	CbGpPWpGaD
Oxprenolol—ADRB2—GPCR downstream signaling—PIK3CA—stomach cancer	9.61e-07	0.000312	CbGpPWpGaD
Oxprenolol—ADRB2—Signaling Pathways—SERPINE1—stomach cancer	9.6e-07	0.000311	CbGpPWpGaD
Oxprenolol—CYP2D6—Metabolism—HMOX1—stomach cancer	9.55e-07	0.00031	CbGpPWpGaD
Oxprenolol—ADRB2—Signaling by GPCR—KRAS—stomach cancer	9.5e-07	0.000308	CbGpPWpGaD
Oxprenolol—ADRB1—Signaling Pathways—RHOA—stomach cancer	9.46e-07	0.000307	CbGpPWpGaD
Oxprenolol—ADRB1—Signaling Pathways—NOS3—stomach cancer	9.37e-07	0.000304	CbGpPWpGaD
Oxprenolol—ADRB2—Signaling Pathways—RHOA—stomach cancer	9.26e-07	0.0003	CbGpPWpGaD
Oxprenolol—ADRB2—Signaling Pathways—NOS3—stomach cancer	9.16e-07	0.000297	CbGpPWpGaD
Oxprenolol—CYP2D6—Metabolism—TYMS—stomach cancer	9.01e-07	0.000292	CbGpPWpGaD
Oxprenolol—ADRB1—Signaling by GPCR—PIK3CA—stomach cancer	8.92e-07	0.00029	CbGpPWpGaD
Oxprenolol—CYP2D6—Metabolism—GSTM1—stomach cancer	8.9e-07	0.000289	CbGpPWpGaD
Oxprenolol—ADRB1—Signaling Pathways—ERBB2—stomach cancer	8.76e-07	0.000284	CbGpPWpGaD
Oxprenolol—ADRB2—Signaling by GPCR—PIK3CA—stomach cancer	8.73e-07	0.000283	CbGpPWpGaD
Oxprenolol—ADRB2—Signaling Pathways—ERBB2—stomach cancer	8.57e-07	0.000278	CbGpPWpGaD
Oxprenolol—CYP2D6—Metabolism—ERCC2—stomach cancer	8.37e-07	0.000272	CbGpPWpGaD
Oxprenolol—ADRB1—Signaling Pathways—CXCL8—stomach cancer	8.31e-07	0.00027	CbGpPWpGaD
Oxprenolol—ADRB1—Signaling by GPCR—HRAS—stomach cancer	8.25e-07	0.000268	CbGpPWpGaD
Oxprenolol—ADRB2—Signaling Pathways—CXCL8—stomach cancer	8.13e-07	0.000264	CbGpPWpGaD
Oxprenolol—ADRB1—Signaling Pathways—CDKN1B—stomach cancer	8.11e-07	0.000263	CbGpPWpGaD
Oxprenolol—ADRB2—Signaling by GPCR—HRAS—stomach cancer	8.07e-07	0.000262	CbGpPWpGaD
Oxprenolol—ADRB2—Signaling Pathways—CDKN1B—stomach cancer	7.94e-07	0.000258	CbGpPWpGaD
Oxprenolol—ADRB1—Signaling by GPCR—IL6—stomach cancer	7.9e-07	0.000256	CbGpPWpGaD
Oxprenolol—CYP2D6—Metabolism—MTHFR—stomach cancer	7.87e-07	0.000255	CbGpPWpGaD
Oxprenolol—ADRB1—Signaling Pathways—CCND1—stomach cancer	7.74e-07	0.000251	CbGpPWpGaD
Oxprenolol—ADRB2—Signaling by GPCR—IL6—stomach cancer	7.73e-07	0.000251	CbGpPWpGaD
Oxprenolol—ADRB1—Signaling Pathways—JUN—stomach cancer	7.72e-07	0.000251	CbGpPWpGaD
Oxprenolol—ADRB2—Signaling Pathways—CCND1—stomach cancer	7.57e-07	0.000246	CbGpPWpGaD
Oxprenolol—ADRB2—Signaling Pathways—JUN—stomach cancer	7.56e-07	0.000245	CbGpPWpGaD
Oxprenolol—ADRB1—Signaling Pathways—MMP9—stomach cancer	7.51e-07	0.000244	CbGpPWpGaD
Oxprenolol—ADRB1—Signaling Pathways—CDKN1A—stomach cancer	7.49e-07	0.000243	CbGpPWpGaD
Oxprenolol—ADRB2—Signaling Pathways—MMP9—stomach cancer	7.35e-07	0.000239	CbGpPWpGaD
Oxprenolol—ADRB2—Signaling Pathways—CDKN1A—stomach cancer	7.32e-07	0.000238	CbGpPWpGaD
Oxprenolol—ADRB1—Signaling Pathways—MAPK8—stomach cancer	7.31e-07	0.000237	CbGpPWpGaD
Oxprenolol—CYP2D6—Metabolism—CAV1—stomach cancer	7.26e-07	0.000235	CbGpPWpGaD
Oxprenolol—CYP2D6—Metabolism—APOA1—stomach cancer	7.24e-07	0.000235	CbGpPWpGaD
Oxprenolol—ADRB2—Signaling Pathways—MAPK8—stomach cancer	7.15e-07	0.000232	CbGpPWpGaD
Oxprenolol—ADRB1—Signaling Pathways—VEGFA—stomach cancer	6.75e-07	0.000219	CbGpPWpGaD
Oxprenolol—ADRB1—Signaling Pathways—STAT3—stomach cancer	6.68e-07	0.000217	CbGpPWpGaD
Oxprenolol—ADRB2—Signaling Pathways—VEGFA—stomach cancer	6.6e-07	0.000214	CbGpPWpGaD
Oxprenolol—ADRB2—Signaling Pathways—STAT3—stomach cancer	6.54e-07	0.000212	CbGpPWpGaD
Oxprenolol—ADRB1—Signaling Pathways—MAPK3—stomach cancer	6.38e-07	0.000207	CbGpPWpGaD
Oxprenolol—CYP2D6—Metabolism—PPARG—stomach cancer	6.38e-07	0.000207	CbGpPWpGaD
Oxprenolol—ADRB2—Signaling Pathways—MAPK3—stomach cancer	6.24e-07	0.000203	CbGpPWpGaD
Oxprenolol—ADRB1—Signaling Pathways—MYC—stomach cancer	6.21e-07	0.000201	CbGpPWpGaD
Oxprenolol—ADRB1—Signaling Pathways—MAPK1—stomach cancer	6.07e-07	0.000197	CbGpPWpGaD
Oxprenolol—ADRB2—Signaling Pathways—MYC—stomach cancer	6.07e-07	0.000197	CbGpPWpGaD
Oxprenolol—ADRB1—Signaling Pathways—EGFR—stomach cancer	6.07e-07	0.000197	CbGpPWpGaD
Oxprenolol—SLC22A2—Metabolism—PIK3CA—stomach cancer	6e-07	0.000195	CbGpPWpGaD
Oxprenolol—ADRB2—Signaling Pathways—MAPK1—stomach cancer	5.94e-07	0.000193	CbGpPWpGaD
Oxprenolol—ADRB2—Signaling Pathways—EGFR—stomach cancer	5.94e-07	0.000193	CbGpPWpGaD
Oxprenolol—ADRB1—Signaling Pathways—KRAS—stomach cancer	5.74e-07	0.000186	CbGpPWpGaD
Oxprenolol—CYP2D6—Metabolism—ALB—stomach cancer	5.74e-07	0.000186	CbGpPWpGaD
Oxprenolol—ADRB2—Signaling Pathways—KRAS—stomach cancer	5.61e-07	0.000182	CbGpPWpGaD
Oxprenolol—CYP2D6—Metabolism—NOS3—stomach cancer	5.49e-07	0.000178	CbGpPWpGaD
Oxprenolol—ADRB1—Signaling Pathways—PIK3CA—stomach cancer	5.27e-07	0.000171	CbGpPWpGaD
Oxprenolol—ADRB2—Signaling Pathways—PIK3CA—stomach cancer	5.16e-07	0.000167	CbGpPWpGaD
Oxprenolol—ADRB1—Signaling Pathways—TP53—stomach cancer	5.1e-07	0.000165	CbGpPWpGaD
Oxprenolol—CYP2D6—Metabolism—PTGS2—stomach cancer	5.02e-07	0.000163	CbGpPWpGaD
Oxprenolol—ADRB2—Signaling Pathways—TP53—stomach cancer	4.99e-07	0.000162	CbGpPWpGaD
Oxprenolol—ADRB1—Signaling Pathways—HRAS—stomach cancer	4.88e-07	0.000158	CbGpPWpGaD
Oxprenolol—ADRB2—Signaling Pathways—HRAS—stomach cancer	4.77e-07	0.000155	CbGpPWpGaD
Oxprenolol—ADRB1—Signaling Pathways—IL6—stomach cancer	4.67e-07	0.000151	CbGpPWpGaD
Oxprenolol—ADRB2—Signaling Pathways—IL6—stomach cancer	4.57e-07	0.000148	CbGpPWpGaD
Oxprenolol—CYP2D6—Metabolism—PIK3CA—stomach cancer	3.09e-07	0.0001	CbGpPWpGaD
